Evaxion Biotech A/S’ $30 Million Initial Public Offering

Accura was local counsel for Oppenheimer & Co. who was lead underwriter in connection with the ADS listing. Mazanti advised Evaxion Biotech.The Danish biotech company Evaxion…

This content is for Standard 1 Year members only.
Login Join Now

Harvey’s Acquisition of Mirage

Citi’s C$1 Billion Notes Offering

Cape’s $61 Million Funding Rounds

Iochpe-Maxion’s R$750 Million Debentures Issuance

Vela Software’s Acquisition of Samtech

Fleury’s R$69,8 Million Acquisition of Sao Lucas Centro de Diagnostico Group

MCI Capital’s Acquisition of Shares in Profitroom

Crescent Petroleum and Crescent Gas Corporation Limited v. National Iranian Oil Company

BeyondNetZero Fund’s Investment in GRESB

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

SC Ventures’ $100 Million Joint Venture With SBI Holdings

GreenCorp’s Acquisition of Emad Bakeries

MedOne’s Agreement with Shikun and Binui Energy

JX Nippon Oil & Gas’ Agreement With Sumitomo Corporation Of Americas For Sustainable Aviation Fuel Project

Bharti Hexacom’s Initial Public Offering

Sustainable Energy Infra Trust’s Loan Financing

Securities Regulation Partner Emily Gordy Joins King & Spalding in Washington, D.C.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Securities Regulation Partner Emily Gordy Joins King & Spalding in Washington, D.C.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Paul Hastings Adds Premier Private Equity Buyout Team

Evaxion Biotech A/S’ $30 Million Initial Public Offering

Author: Federica Tiefenthaler